Suppression of TNF-α mediated apoptosis by EGF in TNF-α sensitive human cervical carcinoma cell line

Growth Factors

Volumn 21, Issue 1, 2003, Pages 31-39

  Akca, Hakan ^a   Akan, Selma Yenisoy ^a   Yanikoglu, Atila ^a   Ozes, Osman Nidai ^b  

^a AKDENIZ UNIVERSITY   (Turkey)

^b InterMune Inc   (United States)

Author keywords

Apoptosis; EGF; p53; PKC ; TNF

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; APOPTOSIS INDUCING FACTOR; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE C DELTA; PROTEIN P21; PROTEIN P53; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RECEPTOR SUBTYPE; RECOMBINANT EPIDERMAL GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN TARGETING; UTERINE CERVIX CARCINOMA;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CYTOSOL; DNA DAMAGE; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FEMALE; GENES, P53; HUMANS; IMMUNOBLOTTING; INDOLES; MALEIMIDES; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; PROTEIN TRANSPORT; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

EID: 0038758826     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.1080/0897719031000115369     Document Type: Article

References (29)

1. Bacer, S.J. and Reddy, E.P. (1998) "Modulation of life and by the TNF receptor superfamily", Oncogene 17, 3261-3270.
2. Barak, Y, Juven, T., Haffner, R. and Oren, M. (1993) "Mdm2 expression is induced by wild type p53 activity, EMBO J. 12, 461-468.
3. Bates, S. and Vousden, K.H. (1996) "P53 signaling checkpoint arrest or apoptosis", Curr. Opin. Genet. Dev. 6, 12-18.
4. Chao, D.T. and Korshmeyer, S.J. (1998) "BCL-2 family regulators of cell death", Annu. Rev. Immunol. 16, 365-419.
5. Deng, C., Zang, P., Harper, J.W., Elledge, S.J. and Leder, P. (1095) "Mice lacking p21 Cip/waf1 undergo normal development but are defective in G1 checkpoint control", Cell 82, 675-684.
6. Donato, N.J. and Perez, M. (1998) "Tumor necrosis factor-induced apoptosis stimulates p53 accumulation and p21/waf1 proteolysis in ME-180 cells", J. Biol. Chem. 273, 5067-5072.
7. El-Diery, S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., et al. (1993) "WAF1, potential mediator of p53 tumor suppression", Cell 75, 817-825.
8. Fisher, D.E. (1994) "Apoptosis in cancer therapy: crossing the threshold", Cell 78, 539-542.
9. Lewis, M., Tartaglia, L.A., Lee, A., Bennett, G.L., Rice, G.C., Wong, G.H., et al. (1991) "Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific", Proc. Natl Acad. Sci. 88, 2830-2834.
10. Liao, L., Ramsey, K. and Jaken, S. (1994) "Protein kinase C isozymes in progressively transformed rat fibroblasts", Cell Growth Differ. 5, 1185-1194.
11. Linzer, D.I. and Lewine, A.J. (1979) "Characterization of a 54 K Dalton cellular SV40 tumor antigen present in SV40-tranformed cells and uninfected embryonal carcinoma cells", Cell 17, 43-52.
12. Lu, Z., Hornia, A., Jiang, Y.W., Zang, Q., Ohno, S. and Foster, D.A. (1997) "Tumor promotion by depleting cells of protein kinase Cδ", Mol. Cell. Biol. 17, 3418-3428.
13. MacEwan, D.J. (2002) "TNF receptor subtype signaling: Differences and cellular consequences", Cellular Signalling 77, 477-492.
14. Mayo, D.L. and Donner, D.B. (2001) "A phosphatidylinositol 3-kinase/AKT pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus", Proc. Natl Acad. Sci. USA 98, 11598-11603.
15. Michael, H.C., Kubbutat, M.H. and Vousden, K.H. (1998) "Keeping an old friend under control: regulation of p53 stability", Mol. Med. Today 4, 250-256.
16. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H.G., Lin, H.K., Liebermann, D.A., et al. (1994) "Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo", Oncogene 9, 1799-1805.
17. Monilola, A.O., Neve, R.M., Lane, H.A. and Hynes, N.E. (2000) "The ErbB signalling network:receptor heterodimerization in development and cancer", EMBO J. 19, 3159-3167.
18. Okomato, K. and Beach, D. (1994) "Cyclin G is a transcriptional target of the p53 tumor suppressor protein", EMBO J. 13, 4816-4822.
19. Oren, M. and Levine, A.J. (1983) "Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen", Proc. Natl Acad. Sci. 80, 56-59.
20. Ozanne, B., Richards, C.S., Hendler, F., Burns, D. and Gusterson, B. (1989) "Overexpression of the EGFR is hallmark of squamous cell carcinomas", J. Pathol. 149, 9-14.
21. Ozes, O.N., Mayo, L.D., Gustin, J.A., Pfeffer, S.R., Pfeffer, L.M. and Donner, D.B. (1999) "NF-kB activation by tumor necrosis factor requires the Akt serine-threonine kinase", Nature 401, 82-85.
22. Price, J.T., Wilson, H.M. and Haites, N.E. (1996) "Epidermal growth factor increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704", Eur. J. Cancer 32, 1977-1982.
23. Romashkova, J.A. and Makarov, S.S. (1999) "NF-kB is a target of Akt in anti-apoptotic PDGF signaling", Nature 401, 86-90.
24. Scheid, M.P. and Woodget, J.R. (2001) "PKB/AKT: Functional insights from genetic models", Nat. Mol. Cell. Biol. Rev. 2, 760-768.
25. Smith, C.A., Davis, T., Anderson, D., Solam, L., Beckmann, M.P., Jerzy, et al. (1990) "A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins", Science 289, 1019-1023.
26. Thompson, C.B. (1995) "Apoptosis in the pathogenesis and treatment of diseases", Science 267, 1456-1462.
27. Verbeek, B.S., Andiansen-slot, S.S., Vroom, T.M., Beckers, T. and Rijksen, G. (1998) "Overexpression of EGFR and c-ErB2 causes enhanced cell migration in human breast cancer cells and NIH3T3 fibroblasts", FEBS Lett. 425, 145-150.
28. Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R. and Beach, D. (1993) "p21 is a universal inhibitor of cyclin kinases", Nature 366, 701-704.
29. Yarden, Y. and Sliwkowski, M.X. (2001) "Untangling the ErbB signalling network", Nature Mol. Cell. Biol. Rev. 2, 127-137.